Rivaroxaban (Xarelto) yl)ethane-1 2-diamine hydrochloride 84 mM) Ethanol 100 mg/mL

84 mM) Ethanol 100 mg/mL (64

heterobifunctional protein crosslinking reagent that is commonly used to crosslink haptens to carrier proteins and enzymes to antibodies

G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of glucocorticoid receptor target genes

2015 Jan 8

Myklebost O

Rivaroxaban (Xarelto) yl)ethane-1 2-diamine hydrochloride 84 mM) Ethanol 100 mg/mLRivaroxaban, also known as BAY 59 7939, is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. If approved by the United States FDA, it will be marketed by Ortho McNeil Pharmaceutical. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 812 hours, but